“The government is also in final negotiations with Sinovac, CanSino and Gamaleya to secure a vaccine supply increase of more than 80% or 26.5 million of the country's total population,” he said in a video on the recent development of Covid-19 vaccine for Malaysians today.
Elaborating, Muhyiddin said the agreements with Sinovac, CanSino and Gamaleya would also provide added value to the local science and technology sectors which would benefit the people and the country’s development. “This includes carrying out vaccine bottling processes in the country, research and development, as well as knowledge sharing and technology transfer,” he said.
Still refering to the theory of the JV is trying to cater the Russian Covid-19 vaccine candidate as one of their targeted product. Based on:
… According to RAFARMA, they are working with one of a Russian national pharmaceutical pioneer established since 1959 with strong research and development team for vaccine research and development in the long-term; where as its existing network with Russian government and European pharmaceutical companies in terms of sourcing, distribution and conduct clinical trial for established vaccines in the short term.
… VaccinesLab advisors on WHO’s listed Covid-19 vaccine clinical trial results especially in terms of safety and efficacy, as well as comparing the research with Russian vaccines currently under various stages of studies, including phase 1 to 3 clinical trials. The team shall propose to VaccinesLab the relevant vaccines deem suitable for ASEAN market in line with WHO updates and standards.
Tomorrow Nexgram will be trading btw 4-4.5 cents....if it gap up to 6 cents, it's time to dispose as this stock will nvr cross the 7 cents level anymore..
GREAT NEWS TO NEXGRAM >> VACCINE...BOTTLING BUSINESS
“This includes carrying out vaccine bottling processes in the country, research and development, as well as knowledge sharing and technology transfer,” he said
& " VACCINES LAB "
Rafarma Pharmaceuticals, Inc.OTC:(RAFA) has signed a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia (https://vaccineslab.com/).
Under the terms of the agreement, Rafarma and Vaccines Lab with create a new jointly-operated vaccine facility in Indonesia to research, develop, conduct clinical trials and license for various in-demand vaccines to combat several viruses. The joint venture will combine the expertise of Vaccines Lab and RAFARMA with its PJSC Kraspharma (OJSC Krasfarma) and R. & D. Biocogency Laboratories Inc. For more information on the virus vaccine efforts of Vaccines Lab, see https://vaccineslab.com/about-vaccinelab/.
*** Watch Out..Pop Corn please >> GAP UP TOMOROWW.......$$$
NEXGRAM >> 6 - 7 SEN EXPLOSIVE WARRANT WC >> 4 - 5 SEN
Malaysia Buys AstraZeneca Covid-19 Vaccine, Negotiating Three Chinese, Russian Vaccines
…. The Malaysian government is finalising agreements to buy Chinese vaccines Sinovac and CanSino, as well as Russia’s Sputnik V shot, that include DOMESTIC FILL-AND-FINISH WORK.
…. The Covid-19 vaccines that have been or will be purchased by the government — Pfizer-BioNTech, the global COVAX Facility, AstraZeneca, Sinovac, CanSino, and Gamaleya — cover 82.8 per cent of Malaysia’s population, or 26.5 million people.
…. Science, Technology and Innovation Minister Khairy Jamaluddin said the Sinovac, CanSino, and Gamaleya vaccine agreements currently being finalised with the Malaysian government would not just include purchasing doses, but also domestic fill-and-finish work and potential tie-ups with the Malaysian research and development (R&D) sector.
PETALING JAYA: The first batch of one million doses of the Pfizer Covid-19 vaccine will be received and given out to target groups as early as February 2021, said PM Moideen
The PM said through all the negotiations and agreements that had been and will be signed, the government will spend a total of US$504.4mil (RM2.05bil).
Elaborating, Moideen said the agreements with Sinovac, CanSino and Gamaleya would also provide added value to the local science and technology sectors which would benefit the people and the country’s development.
“This includes carrying out vaccine bottling processes in the country, research and development, as well as knowledge sharing and technology transfer, ” he said.
The government, in the meantime, will continue to hold talks with other pharmaceutical companies to ensure the country has adequate access to vaccine supply as soon as possible. — Bernama ------------------
VACCINE BOTTLING PROCESS >> DAMN GOOD TO NEXGRAM
# Nexgram acquired Arita medical Acrylic firm, enters vaccine bottling business $$$$$
As Malaysian is going to get free vaccination, so the government is making a direct dealing with vaccines manufacturer which is cheaper than getting supply through co/agents....
NORMAL PRACTICE FOR GOVT BUY SOMETHING THRU COMPANIES.... THIS IS M'SIA BOLEH LAND ...NORM ALREADY $$$$$ DAMN GOOD FUTURE FOR NEXGRAM - ALL ROUNDER COVID BUSINESS INCLUDING VACCINE
8DRAGON...WANT A GUARANTEED RETURN ..NO RISK AT ALL ?... JUST BUY OLD FASHIONED GRANDMA - FIXED DEPOSIT FOR A NEVER FAILED PEANUT@CHICKEEN FEED 2 % IN A YEAR
KUALA LUMPUR: Malaysia is ranked fifth among 17 other developing countries according to a Bloomberg study that gauges their outlook for 2021 based on 11 indicators of economic and financial performance.
In the study, Malaysia is ranked ahead of other Asean countries such as the Philippines (ranked 10) and Indonesia (ranked 12).
Thailand (ranked No. 1) is ahead of Malaysia in the study, while India (ranked 11) and China (ranked 17).
The government is finalising agreements for three vaccine makers to collaborate with local companies and help grow the local pharmaceutical industry, said Special Vaccine Supply Access Guarantee Committee (JKJAV) co-chairperson Khairy Jamaluddin.
A local company will do the fill-finish process for Sinovac's drug – essentially repackaging it into smaller bottles for final distribution. Khairy said this is an essential first step in developing the capacity to manufacture vaccines.- -------------------------
Damn Good for NEXGRAM 's ARITA BOTTLING
Nexgram acquired Arita medical Acrylic firm, enters vaccine bottling business [13 August 2020]
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Singapore88
611 posts
Posted by Singapore88 > 2020-12-22 17:29 | Report Abuse
Loss monies,,again,,he he he